文献速递复苏、休克与脓毒症呼吸衰竭与机械通气重症综合管理与镇静镇痛

超低潮气量通气——实验性心肺复苏中一种新颖有效的通气策略

Ultra-low tidal volume ventilation-A novel and effective ventilation strategy during experimental cardiopulmonary resuscitation.
PubMed 文献 · Resuscitation · 2018-08-31
一句话结论猪室颤CPR模型中,超低潮气量通气(50次/分、2–3 ml/kg)可提供足够氧合通气、降低呼吸与胸内压并减轻肺损伤,作者认为可能改善神经结局,但需进一步研究。

该研究为前瞻性随机对照动物实验,30头雄性德国长白猪(16–20周)诱导室颤后随机分为三组,在机械CPR期间分别接受标准间歇正压通气(IPPV)、CPAP被动氧合或超低潮气量通气(ULTVV),并按指南行高级生命支持最多4个循环,达到ROSC的动物监测6小时后终止实验。结果显示ULTVV在CPR期间提供足够氧合与通气,所需呼吸及胸内压显著更低,V/Q失调显著减少,存活动物肺损伤减轻,脑细胞因子表达显著降低。作者结论认为该策略在猪模型中可行,可能因炎症降低而带来肺保护与神经结局改善,但需进一步研究。

要点

  • 猪室颤CPR模型中,ULTVV(呼吸频率50次/分、潮气量2–3 ml/kg、FiO2 1.0、PEEP 5 mbar)可提供足够氧合与通气。
  • 与标准IPPV和CPAP相比,ULTVV所需呼吸及胸内压显著更低。
  • 与IPPV和CPAP相比,ULTVV组V/Q失调显著减少,存活动物肺损伤减轻。
  • ULTVV组脑细胞因子表达显著降低。
  • 作者结论认为该策略可行、可能带来肺保护与神经结局改善,但需进一步研究。

适用人群与场景

  • 雄性德国长白猪,16–20周龄,麻醉并置管后诱导心室颤动并接受机械CPR的实验动物模型。

处置流程与药物剂量

  • 标准IPPV组:呼吸频率10次/分,潮气量8–9 ml/kg,FiO2 1.0,PEEP 5 mbar。
  • CPAP组:氧流量10 L/min,PEEP 5 mbar。
  • ULTVV组:呼吸频率50次/分,潮气量2–3 ml/kg,FiO2 1.0,PEEP 5 mbar。
  • 所有动物按指南行高级生命支持,最多4个循环;达到ROSC的动物监测6小时后终止实验。

研究设计与关键结果

  • 研究类型:前瞻性随机对照动物实验;样本量:30头雄性德国长白猪(16–20周)。
  • 干预与对照:室颤后机械CPR期间随机分为标准IPPV、CPAP被动氧合或ULTVV三组。
  • 主要结果:ULTVV提供足够氧合与通气,所需呼吸及胸内压显著低于IPPV和CPAP;V/Q失调显著减少;存活动物肺损伤减轻;脑细胞因子表达显著降低。
  • 作者结论:ULTVV在猪CPR模型中可行,可能提供肺保护益处并因炎症降低而改善神经结局;结果需进一步研究,可能最终带来复苏中的新治疗选择。

证据类型、等级与局限

  • 证据类型:前瞻性随机对照动物实验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,猪CPR模型中的ULTVV策略可行,可能提供肺保护益处并因炎症降低而改善神经结局;该结果需进一步研究,可能最终带来复苏中的新治疗选择。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The effects of different ventilation strategies during CPR on patient outcomes and lung physiology are still poorly understood. This study compares positive pressure ventilation (IPPV) to passive oxygenation (CPAP) and a novel ultra-low tidal volume ventilation (ULTVV) regimen in an experimental ventricular fibrillation animal model.

STUDY DESIGN: Prospective randomized controlled trial.

ANIMALS: 30 male German landrace pigs (16-20 weeks).

METHODS: Ventricular fibrillation was induced in anesthetized and instrumented pigs and the animals were randomized into three groups. Mechanical CPR was initiated and ventilation was either provided by means of standard IPPV (RR: 10/min, Vt: 8-9 ml/kg, FiO2: 1,0, PEEP: 5 mbar), CPAP (O2-Flow: 10 l/min, PEEP: 5 mbar) or ULTVV (RR: 50/min, Vt: 2-3 ml/kg, FiO2: 1,0, PEEP: 5 mbar). Guideline-based advanced life support was applied for a maximum of 4 cycles and animals achieving ROSC were monitored for 6 h before terminating the experiment. Ventilation/perfusion ratios were performed via multiple inert gas elimination, blood gas analyses were taken hourly and extended cardiovascular measurements were collected constantly. Brain and lung tissue samples were taken and analysed for proinflammatory cytokine expression.

RESULTS: ULTVV provided sufficient oxygenation and ventilation during CPR while demanding significantly lower respiratory and intrathoracic pressures. V/Q mismatch was significantly decreased and lung injury was mitigated in surviving animals compared to IPPV and CPAP. Additionally, cerebral cytokine expression was dramatically reduced.

CONCLUSION: Ultra-low-volume ventilation during CPR in a porcine model is feasible and may provide lung-protective benefits as well as neurological outcome improvement due to lower inflammation. Our results warrant further studies and might eventually lead to new therapeutic options in the resuscitation setting.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Ruemmler R, Ziebart A, Moellmann C, et al. Ultra-low tidal volume ventilation-A novel and effective ventilation strategy during experimental cardiopulmonary resuscitation. Resuscitation. 2018. PMID: 30176273. doi:10.1016/j.resuscitation.2018.08.031

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。